• en
  • it
  • de
  • Management

    Dr. Oliver Bolzern, PhD
    Chief Executive Officer (CEO)

    Oliver Bolzern studied Chemical Engineering at ETH Zurich, where he also earned his PhD. He has broad international experience, particularly in the fields of operations and development in the pharmaceutical industry. He has been the CEO of the Pharmazell Group since 2006.

    Michel Blanc
    Chief Business Development Officer (CBDO)

    Michel Blanc studied Chemical Engineering and Organic Chemistry in Marseille (France). He started his professional career at ICI and Zeneca, acquiring many years of international experience in different industries. He has more than 15 years of experience in the pharmaceutical industry, working in key decision-making roles in business development for both API and FDF.

    Stephan Bregy
    Chief Sales & Marketing Officer (EVP)

    Stephan Bregy has more than 20 years of experience in the Life Sciences Industry. He has worked in various managerial positions with international responsibilities, at Lonza, DePuy Synthes and Siegfried. Mr. Bregy studied chemistry at the Federal Institute of Technology, Zürich and completed a business degree from the University of Lausanne, Switzerland. He joined PharmaZell as Head of Global Sales and Marketing in March 2017.

    Dr. Edgar Lange
    Chief Financial Officer (CFO)

    Dr. Edgar Lange studied industrial engineering at the university of Karlsruhe (TH) and subsequently received his doctorate in Kiel. After several years consulting McKinsey (Munich and Buenos Aires), he joined the management board of well-known international companies. He started at PharmaZell in September 2020.

    Dr. Kai Donsbach, PhD
    Chief Technology Officer (CTO)

    Dr. Kai Donsbach studied Chemistry at the universities of Mainz and Irvine, California and obtained his PhD in Chemistry from Mainz. He has more than 15 years of international experience in R&D production and project management, working with Boehringer Ingelheim and DSM.

    Dr. Kurt Mayrhofer, PhD
    Chief Compliance Officer (CCO)

    Dr. Kurt Mayrhofer studied food chemistry at LMU Munich, where he also obtained his PhD in Pharmaceutical Chemistry. He is responsible for Global Quality Operations and Regulatory Compliance and is Qualified Person. He has more than 25 years of experience in the pharmaceutical industry and is responsible for the PharmaZell Group compliance program.

    Mario Di Giacomo
    Chief Operating Officer (COO) Europe

    Mario Di Giacomo studied chemical engineering at Bologna University (Italy). He has more than 15 years of experience in project execution, production, technology and management in various fields of the chemical and pharmaceutical industry.

    Anant Barbadikar
    Chief Operating Officer (COO) India

    Anant Barbadikar is a chemical engineering graduate. He has more than twenty years of experience in project execution and manufacturing in various pharmaceutical and chemical industries.